Journal Of Pharmaceutical Analysis

Journal Of Pharmaceutical Analysis

药物分析杂志

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Journal Of Pharmaceutical Analysis》是由Xi'an Jiaotong University出版社于2011年创办的英文国际期刊(ISSN: 2095-1779,E-ISSN: 2214-0883),该期刊长期致力于药学领域的创新研究,主要研究方向为Chemistry-Electrochemistry。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA开放获取模式(OA占比1%),以发表药学领域等方向的原创性研究为核心(研究类文章占比71.68%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在113篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Pharmaceutical Analysis审稿周期约为 22 Weeks 。该刊近年未被列入国际预警名单,年发文量约113篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 113 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
PHARMACOLOGY & PHARMACY 药学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
PHARMACOLOGY & PHARMACY 药学
1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 26 / 354

92.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 8 / 354

97.88%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:16.2 SJR:1.068 SNIP:1.48
学科类别 分区 排名 百分位
大类:Health Professions 小类:Pharmacy Q1 1 / 45

98%

大类:Health Professions 小类:Pharmaceutical Science Q1 5 / 183

97%

大类:Health Professions 小类:Analytical Chemistry Q1 5 / 156

97%

大类:Health Professions 小类:Spectroscopy Q1 3 / 76

96%

大类:Health Professions 小类:Drug Discovery Q1 7 / 157

95%

大类:Health Professions 小类:Electrochemistry Q1 6 / 60

90%

期刊发文

  • Untargeted and targeted mass spectrometry reveal the effects of theanine on the central and peripheral metabolomics of chronic unpredictable mild stress-induced depression in juvenile rats

    Author: Zhu, Yanru; Wang, Feng; Han, Jiatong; Zhao, Yunli; Yu, Miao; Ma, Mingyan; Yu, Zhiguo

    Journal: JOURNAL OF PHARMACEUTICAL ANALYSIS. 2023; Vol. 13, Issue 1, pp. 73-87. DOI: 10.1016/j.jpha.2022.10.001

  • Neurotoxicity mechanism of aconitine in HT22 cells studied by microfluidic chip-mass spectrometry

    Author: Zhang, Yingrui; Chen, Shiyu; Fan, Fangfang; Xu, Ning; Meng, Xian-Li; Zhang, Yi; Lin, Jin-Ming

    Journal: JOURNAL OF PHARMACEUTICAL ANALYSIS. 2023; Vol. 13, Issue 1, pp. 88-98. DOI: 10.1016/j.jpha.2022.11.007

  • Integrated top-down and bottom-up proteomics mass spectrometry for the characterization of endogenous ribosomal protein heterogeneity

    Author: Zhang, Ying; Cai, Qinghua; Luo, Yuxiang; Zhang, Yu; Li, Huilin

    Journal: JOURNAL OF PHARMACEUTICAL ANALYSIS. 2023; Vol. 13, Issue 1, pp. 63-72. DOI: 10.1016/j.jpha.2022.11.003

  • Inosine: A broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation

    Author: Wang, Ningning; Li, Entao; Deng, Huifang; Yue, Lanxin; Zhou, Lei; Su, Rina; He, Baokun; Lai, Chengcai; Li, Gaofu; Gao, Yuwei; Zhou, Wei; Gao, Yue

    Journal: JOURNAL OF PHARMACEUTICAL ANALYSIS. 2023; Vol. 13, Issue 1, pp. 11-23. DOI: 10.1016/j.jpha.2022.10.002

  • Boosting ferroptosis and microtubule inhibition for antitumor therapy via a carrier-free supermolecule nanoreactor

    Author: Mu, Min; Liang, Xiaoyan; Zhao, Na; Chuan, Di; Chen, Bo; Zhao, Shasha; Wang, Guoqing; Fan, Rangrang; Zou, Bingwen; Han, Bo; Guo, Gang

    Journal: JOURNAL OF PHARMACEUTICAL ANALYSIS. 2023; Vol. 13, Issue 1, pp. 99-109. DOI: 10.1016/j.jpha.2022.09.003

  • The interaction between polyphyllin I and SQLE protein induces hepatotoxicity through SREBP-2/HMGCR/SQLE/LSS pathway

    Author: Li, Zhiqi; Fan, Qiqi; Chen, Meilin; Dong, Ying; Li, Farong; Wang, Mingshuang; Gu, Yulin; Guo, Simin; Ye, Xianwen; Wu, Jiarui; Dai, Shengyun; Lin, Ruichao; Zhao, Chongjun

    Journal: JOURNAL OF PHARMACEUTICAL ANALYSIS. 2023; Vol. 13, Issue 1, pp. 39-54. DOI: 10.1016/j.jpha.2022.11.005

  • Evaluation of immunoprotection against coronavirus disease 2019 Novel variants, vaccine inoculation, and complications

    Author: Jiang, Congshan; Jiang, Kaichong; Li, Xiaowei; Zhang, Ning; Zhu, Wenhua; Meng, Liesu; Zhang, Yanmin; Lu, Shemin

    Journal: JOURNAL OF PHARMACEUTICAL ANALYSIS. 2023; Vol. 13, Issue 1, pp. 1-10. DOI: 10.1016/j.jpha.2022.10.003

  • Epigenetic drug library screening reveals targeting DOT1L abrogates NAD plus synthesis by reprogramming H3K79 methylation in uveal melanoma

    Author: Gu, Xiang; Hua, Yu; Yu, Jie; Yang, Ludi; Ge, Shengfang; Jia, Renbing; Chai, Peiwei; Zhuang, Ai; Fan, Xianqun

    Journal: JOURNAL OF PHARMACEUTICAL ANALYSIS. 2023; Vol. 13, Issue 1, pp. 24-38. DOI: 10.1016/j.jpha.2022.11.008